Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Patrizia Ancona"'
Autor:
Filomena Corbo, Alessia Carocci, Domenico Armenise, Nicolino De Laurentis, Antonio Laghezza, Fulvio Loiodice, Patrizia Ancona, Marilena Muraglia, Vincenzo Pagliarulo, Carlo Franchini, Alessia Catalano
Publikováno v:
Journal of Chemistry, Vol 2016 (2016)
A series of N-1,3-benzothiazol-2-ylbenzamide derivatives were studied for their antiproliferative activity on human liver hepatocellular carcinoma (HepG2) and human breast cancer (MCF-7) cell lines. Most of them were found to show a prominent inhibit
Externí odkaz:
https://doaj.org/article/acad5678e9544c1297a54c9c1c197cae
Autor:
Vincenzo Pagliarulo, Patrizia Ancona, Ivan Martines, Rossana Spadavecchia, Savino Di Stasi, Stefano Alba, Luigi Cormio, Caterina Fanizza, Annamaria Salerno, Giuseppe Carrieri, Arcangelo Pagliarulo
Publikováno v:
Therapeutic Advances in Urology, Vol 7 (2015)
Objectives: New targets and approaches are under investigation for the treatment of nonmuscle invasive bladder cancer (NMIBC). Preclinical data suggest cyclooxygenase-2 (COX-2) as a promising target. Celecoxib, a COX-2 selective inhibitor, inhibits t
Externí odkaz:
https://doaj.org/article/d6974079adf2417699e99312c92e85f3
Autor:
Patrizia Ancona, Donato F. Altomare
Publikováno v:
Nutritional Support after Gastrointestinal Surgery ISBN: 9783030165536
Total or partial resection of the stomach is a major surgery performed mainly for complications of peptic ulcers (bleeding, stricture, perforation) or for gastric cancer. Other less frequent indications are benign tumors and severe gastroparesis. Gas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::822192575f6b1a7b42185bc21e522a23
https://doi.org/10.1007/978-3-030-16554-3_3
https://doi.org/10.1007/978-3-030-16554-3_3
Autor:
Annamaria Salerno, Giuseppe Carrieri, Pasquale Ditonno, Luigi Cormio, Rossana Spadavecchia, Patrizia Ancona, Vincenzo Pagliarulo, Buscarini Maurizio, Tommasangelo Petitti, Savino M. Di Stasi
Estimation of prognosis is patients undergoing radical cystectomy is often unreliable, as occult disease remains undetected by conventional diagnostic tools. The purpose of this study was to evaluate the feasibility and the clinical significance of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c82767662297bc85be7ff1f005470cb3
http://hdl.handle.net/2108/193176
http://hdl.handle.net/2108/193176
Autor:
Francesco Berardi, Vincenzo Pagliarulo, Carmela Inglese, Mauro Niso, Roberto Perrone, Nicola Antonio Colabufo, Patrizia Ancona, Arcangelo Pagliarulo, Giancarlo Albo, Marialessandra Contino
Publikováno v:
European Journal of Pharmacology. 601:38-42
article i nfo Keywords: Bicalutamide Calcein-AM P-glycoprotein BCRP MRP1 Prolonged bicalutamide treatment induced pathology regression although relapses with a more aggressive form of prostate cancer have been observed. This failure could be due to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346b8acf2b3e18cf3ca1a3c357e83c8f
https://doi.org/10.1016/j.ejphar.2008.10.038
https://doi.org/10.1016/j.ejphar.2008.10.038
Autor:
Nicolino De Laurentis, Alessia Carocci, Fulvio Loiodice, Antonio Laghezza, Marilena Muraglia, Alessia Catalano, Filomena Corbo, Vincenzo Pagliarulo, Patrizia Ancona, Domenico Armenise, Carlo Franchini
Publikováno v:
Journal of Chemistry, Vol 2016 (2016)
A series ofN-1,3-benzothiazol-2-ylbenzamide derivatives were studied for their antiproliferative activity on human liver hepatocellular carcinoma (HepG2) and human breast cancer (MCF-7) cell lines. Most of them were found to show a prominent inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::311fb986b47a1ded41dc3c83b47eb8ab
Autor:
Savino M. Di Stasi, Giuseppe Carrieri, Ivan Martines, Rossana Spadavecchia, Annamaria Salerno, Vincenzo Pagliarulo, Stefano Alba, Caterina Fanizza, Patrizia Ancona, Arcangelo Pagliarulo, Luigi Cormio
Publikováno v:
Therapeutic Advances in Urology, Vol 7 (2015)
Objectives: New targets and approaches are under investigation for the treatment of nonmuscle invasive bladder cancer (NMIBC). Preclinical data suggest cyclooxygenase-2 (COX-2) as a promising target. Celecoxib, a COX-2 selective inhibitor, inhibits t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df1a028d5508a34d30cbddd37e15aea0
https://doaj.org/article/d6974079adf2417699e99312c92e85f3
https://doaj.org/article/d6974079adf2417699e99312c92e85f3
Autor:
Patrizia Ancona, Arcangelo Pagliarulo, Luigi Cormio, Nicola Antonio Colabufo, Vincenzo Pagliarulo, Mauro Niso, Marialessandra Contino, Amalia Azzariti
Publikováno v:
Molecular Cancer
Background: An in vitro model was developed to understand if celecoxib could synergize with Mitomycin C (MMC), commonly used for the prevention of non-muscle invasive bladder cancer recurrence, and eventually elucidate if the mechanism of interaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffc750d21f81dbd0cad26ef900ba836
http://europepmc.org/articles/PMC3669624
http://europepmc.org/articles/PMC3669624